A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
about
The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease.NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.The impact of genetics on future drug discovery in schizophrenia.Exploration and characterisation of the phenotypic and genetic profiles of patients with early onset schizophrenia associated with autism spectrum disorder and their first-degree relatives: a French multicentre case series study protocol (GenAuDiss)
P2860
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
@en
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
@nl
type
label
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
@en
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
@nl
prefLabel
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
@en
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
@nl
P2093
P2860
P50
P356
P1476
A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.
@en
P2093
Catherine A Brownstein
Elisa Gonzalez-Cuevas
Gerard T Berry
Joseph Gonzalez-Heydrich
Meghan C Towne
Min-Joon Han
Niklas Smedemark-Margulies
Pankaj B Agrawal
Sahil K Tembulkar
Sigella Vargas
P2860
P304
P356
10.1101/MCS.A001008
P577
2016-09-01T00:00:00Z